2Suresh Karne MD, PhD, Fred S, et al. Etiopathogenesis of acute pancreatitis[ J]. Surg Clin North Am,1999,79(4) :699-710.
3Andreas Oberholzer M D, Caroline Oberholzer M D ,Lyle L, et al. Cytokine singling-regulation of the immune response in normal and critically ill states [ J ]. Crit Care Meal, 2000, 28 ( 4 ) :4 -12.
4Steven M, Opal M D, Vera A,et al. Anti-inflammatory cytokines[J].Chest.2000.117(4) :1162-1172.
5Roger C, Bone MD. Immunologic dissonance : A continuing evolution in our understanding of the systemic inflammatory response syndrome (SlRS) and the multiple organ dysfunction syndrome (MODS) [J]. Ann Inter Med,1996,125(8) :680-685.
6Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation [J].World J Surg, 1996,20 (4) :454459.
7Norman J, Yang J, Fink G, et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme(ICE) [J]. J Interferon Cytokine Res,1997,17(2) :113-118.
8Fink G, Yang J, Carter G, et al. Acute pancreatitis induced enzyme release and necrosis are attenuated by IL-1 antagonism through an indirect mechanism[J]. J Surg Res, 1997,67 ( 1 ) :94-97.
9Hughes CB,Gaber LW ,Moheyel Din AB,et al. Inhibition of TNF-α improves survival in an experimental model of acute pancreatitis [J]. Am Surg, 1996,62( 1 ) :8-13.
10Luiten EJ ,Hop WC ,Lange JF,et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis[ J]. Ann Surg,1995,222( 1 ) :57-65.
